GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have transformed how doctors treat obesity and diabetes. Here is a complete plain-language guide to understanding them.
What Are GLP-1 Drugs?
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating. GLP-1 receptor agonist drugs mimic this hormone, helping to regulate blood sugar, slow digestion, and reduce appetite.
The Most Common GLP-1 Drugs in 2026
- Ozempic (semaglutide) — approved for type 2 diabetes, widely used for weight loss
- Wegovy (semaglutide) — higher dose version approved specifically for obesity
- Mounjaro / Zepbound (tirzepatide) — dual GLP-1/GIP agonist, strongest currently approved
- Victoza / Saxenda (liraglutide) — older, less powerful, daily injection
Who Qualifies for a GLP-1 Prescription?
- Adults with type 2 diabetes (for Ozempic, Victoza)
- Adults with BMI 30+ (obesity) for weight loss versions
- Adults with BMI 27+ with at least one weight-related condition
How to Get a Prescription
- Schedule an appointment with your primary care doctor or an endocrinologist.
- Discuss your weight and health history.
- Ask specifically about GLP-1 options for your situation.
- If approved, the prescription is sent to your pharmacy.
How Much Do GLP-1 Drugs Cost?
Without insurance, GLP-1 drugs typically cost $900–$1,400 per month. With insurance or Medicare Part D, many patients pay $0–$50/month. Manufacturer savings cards (from Novo Nordisk and Eli Lilly) can also reduce costs significantly.